Skip to main content

Part of the book series: Springer Theses ((Springer Theses))

Abstract

There is growing evidence that conventional chemotherapeutics can modulate the immune system and trigger an immune response which sustains a long term durable therapeutic outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Galluzzi, L., Senovilla, L., Zitvogel, L., Kroemer, G.: The secret ally: immunostimulation by anticancer drugs. Nat. Rev. Drug Discov. 11, 215–233 (2012)

    Article  CAS  PubMed  Google Scholar 

  2. Zitvogel, L., Galluzzi, L., Smyth, M.J., Kroemer, G.: Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 39, 74–88 (2013)

    Article  CAS  PubMed  Google Scholar 

  3. Mattarollo, S.R., Loi, S., Duret, H., Ma, Y., Zitvogel, L., Smyth, M.J.: Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. Cancer Res. 71, 4809–4820 (2011)

    Article  CAS  PubMed  Google Scholar 

  4. Halama, N., Michel, S., Kloor, M., Zoernig, I., Benner, A., Spille, A., Pommerencke, T., von Knebel, D.M., Folprecht, G., Luber, B., Feyen, N., Martens, U.M., Beckhove, P., Gnjatic, S., Schirmacher, P., Herpel, E., Weitz, J., Grabe, N., Jaeger, D.: Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. Cancer Res. 71, 5670–5677 (2011)

    Article  CAS  PubMed  Google Scholar 

  5. Dieci, M.V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M.C., Delaloge, S., Curigliano, G., Andre, F.: Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann. Oncol. 25, 611–618 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kroemer, G., Galluzzi, L., Kepp, O., Zitvogel, L.: Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31, 51–72 (2013)

    Article  CAS  PubMed  Google Scholar 

  7. Krysko, D.V., Garg, A.D., Kaczmarek, A., Krysko, O., Agostinis, P., Vandenabeele, P.: Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860–875 (2012)

    Article  CAS  PubMed  Google Scholar 

  8. Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G.M., Apetoh, L., Perfettini, J.L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., Metivier, D., Larochette, N., van Endert, P., Ciccosanti, F., Piacentini, M., Zitvogel, L., Kroemer, G.: Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54–61 (2007)

    Article  CAS  PubMed  Google Scholar 

  9. Menger, L., Vacchelli, E., Adjemian, S., Martins, I., Ma, Y., Shen, S., Yamazaki, T., Sukkurwala, A. Q., Michaud, M., Mignot, G., Schlemmer, F., Sulpice, E., Locher, C., Gidrol, X., Ghiringhelli, F., Modjtahedi, N., Galluzzi, L.; André, F., Zitvogel, L., Kepp, O., Kroemer, G.: Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci. Transl. Med. 4, 143ra99 (2012)

    Article  CAS  PubMed  Google Scholar 

  10. Kepp, O., Menger, L., Vacchelli, E., Locher, C., Adjemian, S., Yamazaki, T., Martins, I., Sukkurwala, A.Q., Michaud, M., Senovilla, L., Galluzzi, L., Kroemer, G., Zitvogel, L.: Crosstalk between ER stress and immunogenic cell death. Cytokine Growth Factor Rev. 24, 311–318 (2013)

    Article  CAS  PubMed  Google Scholar 

  11. Chao, M.P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A.A., Gentles, A.J., Volkmer, J., Weiskopf, K., Willingham, S.B., Raveh, T., Park, C.Y., Majeti, R., Weissman, I.L.: Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci. Transl. Med. 2, 63ra94 (2010)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Tesniere, A., Schlemmer, F., Boige, V., Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., Mendiboure, J., Pignon, J.P., Jooste, V., van Endert, P., Ducreux, M., Zitvogel, L., Piard, F., Kroemer, G.: Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 29, 482–491 (2009)

    Article  CAS  PubMed  Google Scholar 

  13. Shah, N., Dizon, D.S.: New-generation platinum agents for solid tumors. Future Oncol. 5, 33–42 (2009)

    Article  CAS  PubMed  Google Scholar 

  14. Park, G.Y., Wilson, J.J., Song, Y., Lippard, S.J.: Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile. Proc. Natl. Acad. Sci. U. S. A. 109, 11987–11992 (2012)

    Article  PubMed  PubMed Central  Google Scholar 

  15. Bhargava, A., Vaishampayan, U.N.: Satraplatin: leading the new generation of oral platinum agents. Expert Opin. Investig. Drugs 18, 1787–1797 (2009)

    Article  CAS  PubMed  Google Scholar 

  16. Holford, J., Sharp, S.Y., Murrer, B.A., Abrams, M., Kelland, L.R.: In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473. Br. J. Cancer 77, 366–373 (1998)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zou, T., Lok, C.N., Fung, Y.M., Che, C.M.: Luminescent organoplatinum(II) complexes containing bis(N-heterocyclic carbene) ligands selectively target the endoplasmic reticulum and induce potent photo-toxicity. Chem. Commun. 49, 5423–5425 (2013)

    Article  CAS  Google Scholar 

  18. Hoffmann, P.R., deCathelineau, A.M., Ogden, C.A., Leverrier, Y., Bratton, D.L., Daleke, D.L., Ridley, A.J., Fadok, V.A., Henson, P.M.: Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155, 649–659 (2001)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Savill, J., Dransfield, I., Gregory, C., Haslett, C.: A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965–975 (2002)

    Article  CAS  PubMed  Google Scholar 

  20. Gardai, S.J., McPhillips, K.A., Frasch, S.C., Janssen, W.J., Starefeldt, A., Murphy-Ullrich, J.E., Bratton, D.L., Oldenborg, P.-A., Michalak, M., Henson, P.M.: Cell-Surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321–334 (2005)

    Article  CAS  PubMed  Google Scholar 

  21. Garg, A., Krysko, D., Vandenabeele, P., Agostinis, P.: Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol. Immunother. 61, 215–221 (2012)

    Article  CAS  PubMed  Google Scholar 

  22. Garg, A.D., Krysko, D.V., Verfaillie, T., Kaczmarek, A., Ferreira, G.B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A.J.M., Annaert, W., Golab, J., de Witte, P., Vandenabeele, P., Agostinis, P.: A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 31, 1062–1079 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Garg, A.D., Krysko, D.V., Vandenabeele, P., Agostinis, P.: The emergence of phox-ER stress induced immunogenic apoptosis. OncoImmunology 1, 786–788 (2012)

    Article  PubMed  PubMed Central  Google Scholar 

  24. Inoue, H., Tani, K.: Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ. 21, 39–49 (2014)

    Article  CAS  PubMed  Google Scholar 

  25. Hempel, S.L., Buettner, G.R., O’Malley, Y.Q., Wessels, D.A., Flaherty, D.M.: Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic. Biol. Med. 27, 146–159 (1999)

    Article  CAS  PubMed  Google Scholar 

  26. Costes, S.V., Daelemans, D., Cho, E.H., Dobbin, Z., Pavlakis, G., Lockett, S.: Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86, 3993–4003 (2004)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Wang, X., Olberding, K.E., White, C., Li, C.: Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis. Cell Death Differ. 18, 38–47 (2011)

    Article  CAS  PubMed  Google Scholar 

  28. Sukkurwala, A.Q., Adjemian, S., Senovilla, L., Michaud, M., Spaggiari, S., Vacchelli, E., Baracco, E.E., Galluzzi, L., Zitvogel, L., Kepp, O., Kroemer, G.: Screening of novel immunogenic cell death inducers within the NCI mechanistic diversity set. OncoImmunology 3, e28473 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wong, D.Y.Q., Yeo, C.H.F., Ang, W.H.: Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents. Angew. Chem. Int. Ed. 53, 6752–6756 (2014)

    Article  CAS  Google Scholar 

  30. Dhara, S.C.: A rapid method for the synthesis of cis-[Pt(NH3)2Cl2]. Indian J. Chem. 8, 193–194 (1970)

    Google Scholar 

  31. Pepels, A., Rauter, H., Schnebeck, R.D., Wissmann, F.: Process for the preparation of 1,2-diaminocyclohexane-platinum(II) complexes. In Google Patents (2007)

    Google Scholar 

  32. Chin, C.F., Tian, Q., Setyawati, M.I., Fang, W., Tan, E.S., Leong, D.T., Ang, W.H.: Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation. J. Med. Chem. 55, 7571–7582 (2012)

    Article  CAS  PubMed  Google Scholar 

  33. Zhang, J.Z., Bonnitcha, P., Wexselblatt, E., Klein, A.V., Najajreh, Y., Gibson, D., Hambley, T.W.: Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design. Chem. Eur. J. 19, 1672–1676 (2013)

    Article  CAS  PubMed  Google Scholar 

  34. Battle, A.R., Choi, R., Hibbs, D.E., Hambley, T.W.: Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies. Inorg. Chem. 45, 6317–6322 (2006)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Yuan Qiang Wong .

Supplementary Information

Supplementary Information

Supplementary Figures

Fig. S6.1
figure 7figure 7

Cells observed under confocal microscopy after drug treatment (4 h) and incubation with H2DCFDA (ROS indicator, green) and ER-Tracker Red (red). a CT-26. b MDA-MB-231. c Colocalisation analysis after Pt-NHC treatment (1 μM) on MDA-MB-231. White pixels indicate areas of colocalisation as determined by Costes method

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wong, D.Y.Q. (2018). Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes. In: Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches. Springer Theses. Springer, Singapore. https://doi.org/10.1007/978-981-10-8594-9_6

Download citation

Publish with us

Policies and ethics